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Purpose: Our previous work identified 23 low molecular weight (<3.5 kDa) crystallin peptides in the urea-soluble fractions
of normal young, normal aged, and aged cataract human lenses. We found that one of these crystallin fragments, βA3/
A1102–117 peptide (SDAYHIERLMSFRPIC), that are present in aged and cataract lens, increased the scattering of light by
β- and γ-crystallins and alcohol dehydrogenase (ADH) and also reduced the chaperone-like activity of αB-crystallin. The
present study was performed to identify the interacting sites of the βA3/A1102–117 peptide in αB-crystallin.
Methods:  βA3/A1102–117  peptide  was  first  derivatized  with  sulfo-succinimidyl-2-[6-(biotinamido)-2-{p-
azidobenzamido}-hexanoamido] ethyl-1–3 dithio propionate (sulfo-SBED), a photoactivable, heterotrifunctional biotin-
containing cross-linker. The biotin-derivatized peptide was then incubated with αB-crystallin at 37 °C for 2 h to allow
complex formation followed by photolysis to facilitate the transfer of the biotin label from the peptide to αB-crystallin.
Label transfer was confirmed by western blot, and the labeled αB-crystallin was digested with trypsin. Tryptic peptides
from αB-crystallin carrying the biotin label were purified by avidin affinity chromatography, and βA3/A1102–117 peptide
interacting  sites  in  αB-crystallin  were  identified  by  matrix-assisted  laser  desorption  ionization-time-of-flight  mass
spectrometry (MALDI-TOF MS) and nanospray quadrupole time-of-flight mass spectrometry (QqTOF MS/MS).
Results: We found that the βA3/A1102–117 peptide interacted with αB-crystallin regions 70LEKDR74, 83HFSPEELKVK92,
91VKVLGDVIEVHGK103, 93VLGDVIEVHGKHEER107, and 121KYR123, which are part of the α-crystallin domain, and
were previously shown to be part of the functional chaperone site in αB-crystallin. The βA3/A1102–117 peptide also
interacted with regions at the COOH-terminal extension of αB-crystallin, 150KQVSGPER157, 164EEKPAVTAAPK174, and
164EEKPAVTAAPKK175. When two of the hydrophobic residues of βA3/A1102–117 peptide were replaced with hydrophilic
residues, the resulting substituted peptide, SDADHGERLMSFRPIC, did not show the anti-chaperone property.
Conclusions: This study confirmed the interactions between a low molecular weight peptide derived from βA3/A1-
crystallin found in aged and cataract lenses and αB-crystallin. The binding of βA3/A1102–117 peptide to the chaperone site
and the COOH-terminal extension of αB-crystallin may explain its anti-chaperone property.
Human lens crystallins are organized into three classes,
α-, β-, and γ-crystallins, based on sequence homology and the
size  of  aggregates  isolated  under  physiologic  conditions.
Since lens crystallins undergo little or no turnover, there is
opportunity for numerous post-translational modifications as
the lens ages [1-4]. Some modifications of lens crystallins
identified  in  young  clear  lenses  may  reflect  normal
development and maturation of the lens [5,6] whereas other
modifications  associated  with  aged  lenses-  such  as
deamidation,  phosphorylation,  truncation,  glycation,
oxidation,  and  cross-linking  could  negatively  impact
crystallin  conformation,  aggregation  state,  or  solubility,
resulting in increased light scattering and eventual loss of
transparency in aged lenses [7-10].
In comparison to normal lenses, cataract lenses show
greater  fragmentation  of  crystallins  due  to  proteolysis  [1,
11-13].  Increased  crystallin  fragmentation  has  also  been
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reported in aged and cataract lenses of non-human species
[6,14-17].  It  has  been  reported  that  proteolysis  may  be  a
contributing  factor  in  the  insolubilization  of  crystallins
occurring during normal maturation of lens or during cataract
formation in human and bovine lenses [18]. It has been shown
that  the  fragments  of  βA3/A1-  and  βB1-crystallins  are
selectively  insolubilized  during  cataract  development
compared to normal aging [13]. These authors also reported
increased crystallin truncation, the deamidation of Asn to Asp
residues, and the oxidation of a Trp residue in cataract lenses.
Several proteolytic enzymes have been shown to play a
role  in  aging  of  the  lens  and  cataract  formation  [19-25].
Activities of several peptidases were reported to be highest in
the outer cortical fibers and decreased to one half or below in
the inner cortical fibers and nucleus. An inverse correlation
between  peptidase  activities  and  the  amount  of  crystallin
fragments was observed in different regions of the lens. The
amount  of  crystallin  fragments  and  the  amount  of  water-
insoluble proteins were greater in the lens nucleus than in the
outer  cortical  fibers  [21].  An  age-dependent  decline  in
proteasome  activity  and  a  concomitant  accumulation  of
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666modified proteins in human lens has been reported earlier
[26]. Increased opacification of the lens nucleus in cataract
was  significantly  correlated  with  decreased  peptidase
activities of the proteasome [27]. Although a protein oxidation
reaction may render the protein susceptible to proteolysis,
heavily oxidized proteins appear to first aggregate (via new
hydrophobic and ionic bonds) and then to form covalent cross-
links that make them highly resistant to proteolysis by 20S
proteasome  [28].  In  fact,  these  aggregated,  cross-linked
oxidized proteins actually bind to the 20S proteasome and
inhibit  its  ability  to  degrade  the  oxidized  forms  of  other
proteins [29].
Low molecular weight crystallin fragments have been
isolated and characterized from both the water-soluble and
water-insoluble fractions of the lens with greater prevalence
in the water-insoluble fractions [11,21,30-32]. As many as 13
crystallin fragments with molecular masses between 3 and 17
kDa and originating from α-, β-, and γ-crystallins have been
isolated  from  the  water-soluble,  high  molecular  weight
aggregates  of  60-80-year-old  human  lenses  [31].
Accumulation of such crystallin fragments may be a cause for
age-related lens opacity. It has been hypothesized that the
interaction of short peptides derived from crystallins with lens
proteins may increase the formation of high molecular weight
aggregates  and  the  scattering  of  light  [33].  Though  it  is
hypothesized that cataract develops as a result of improper
interaction of crystallin fragments generated by proteolysis
[25], the underlying mechanism is not clear. Earlier work by
our group has shown that in vitro-oxidized crystallin peptides
enhance the aggregation of βL-crystallin and γ-crystallin and
also  exhibit  anti-chaperone-like  properties  [33-35].
Interaction of peptide fragments with lens proteins and their
aggregation-enhancing nature may have some implications
for age-related cataract formation.
Recent  studies  in  our  laboratory  have  revealed  the
presence of 23 low molecular weight (<3.5 kDa) peptides in
the urea-soluble fractions of normal young, normal aged, and
aged  cataract  human  lenses,  and  the  amount  of  crystallin
fragments was found to increase with age [36]. Out of these
23 peptides, 15 were derived from αA- and αB-crystallin.
Most of the 15 came from the NH2-terminal region, a few from
the α-crystallin domain, and none from the COOH-terminal
extension. Two crystallin peptides predominant in the nucleus
of aged lens and cataract lens but not in young lens, αB1–18
(MDIAIHHPWIRRPFFPFH,  GenBank  NP_001876)  and
βA3/A1102–117  (SD(N)AYHIERLMSFRPIC,  GenBank
NP_005199), increased the molecular mass, polydispersity,
and hydrodynamic radius of αA- and αB-crystallins [36]. Our
study also showed that the peptides, αB1–18 and βA3/A1102–
117, increased the scattering of light by β- and γ-crystallins and
alcohol  dehydrogenase  (ADH)  and  also  reduced  the
chaperone-like activity of α-crystallin.
The present study was undertaken to identify the binding
sites for the βA3/A1102–117 peptide in αB-crystallin. We used
the  photoactive  cross-linker  sulfo-SBED  (sulfo-
succinimidyl-2-[6-(biotinamido)-2-{p-azidobenzamido}-
hexanoamido] ethyl-1–3 dithio propionate) [37] to confirm
the interaction between αB-crystallin and the βA3/A1102–117
peptide. The βA3/A1102–117 peptide interacting sites in αB-
crystallin are reported here.
METHODS
Reagents:  Trypsin  gold  (mass  spectrometry  grade)  was
purchased from Promega Corporation (Madison, WI). Sulfo-
SBED,  immobilized  monomeric  avidin  kit,  and  micro-
bicinchoninic acid (BCA) protein assay kit were procured
from Pierce (Rockford, IL). Trypsin inhibitor, TLCK (N α-p-
tosyl-L-lysine  chloromethyl  ketone),  was  obtained  from
Sigma Chemical Company (St. Louis, MO). The βA3/A1102–
117  peptide,  SDAYHIERLMSFRPIC,  and  the  substituted
peptide, SDADHGERLMSFRPIC (in which the tyrosine and
isoleucine corresponding to 105 and 107 in βA3/A1-crystallin
are replaced by aspartate and by glycine, respectively), were
synthesized at the University of Missouri core facility and
purified by HPLC. Their masses (1936.9 Da and 1833 Da,
respectively)  were  ascertained  by  matrix-assisted  laser
desorption  ionization-time-of-flight  mass  spectrometry
(MALDI-TOF  MS).  Blotting  grade  avidin-horseradish
peroxidase  conjugate  was  obtained  from  Bio-Rad
Laboratories  (Hercules,  CA).  Bovine  βL-crystallin  was
isolated  from  lens  extract  using  the  procedure  described
earlier [35]. All other chemicals were of analytical grade.
Synthesis of recombinant human αB-crystallin: Human αB-
crystallin cDNA (obtained from J.M. Petrash, Washington
University, St. Louis, MO) was cloned into the pET-23d (+)
vector (Novagen, Madison, WI), and the recombinant protein
was expressed in Escherichia coli BL21(DE3) pLysS cells
(Invitrogen,  Carlsbad,  CA)  as  described  earlier  [38].  The
protein  was  purified  by  size  exclusion  chromatography
followed  by  ion-exchange  chromatography  as  described
previously [39].
Effect of βA3/A1102–117 peptide on the thermal aggregation of
βL-crystallin and the chaperone function of αB-crystallin: The
βA3/A1102–117 peptide (SDAYHIERLMSFRPIC) as well as
the  substituted  peptide  (SDADHGERLMSFRPIC)  were
dissolved in 50 μl of DMSO and diluted to 0.5 ml with 0.05
M  phosphate  buffer  containing  0.15  M  NaCl  (pH  7.4),
hereafter referred to as phosphate buffered saline (PBS). The
peptide concentration was measured using the micro-BCA
assay  method.  Thermal  aggregation  assay  of  bovine  βL-
crystallin  and  chaperone  assay  of  αB-crystallin  were
performed  according  to  the  method  previously  described
[35]. Briefly, substrate protein, βL-crystallin (100 μg), was
heat-denatured at 55 °C in 1 ml of PBS for 60 min in the
presence or absence of αB-crystallin (5 μg) and the βA3/
A1102–117  peptide  or  the  substituted  peptide  (60  μg).
Aggregation was monitored by recording the light scattering
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667at 360 nm as a function of time at 55 °C in a Shimadzu
spectrophotometer  equipped  with  a  temperature-controlled
multicell transporter.
Effect  of  pre-incubation  with  βA3/A1102–117  peptide  on  the
chaperone function of αB-crystallin: To determine whether
prior  binding  of  the  βA3/A1102–117  peptide  alters  the
chaperone-like activity of αB-crystallin toward denaturing
proteins, 50 μg of αB-crystallin was incubated with 100 μg of
βA3/A1102–117 in a total volume of 0.2 ml of PBS at 37 °C for
12 h. A sample containing αB-crystallin alone served as a
control.  After  the  incubation,  samples  were  briefly
centrifuged  to  separate  any  visible  precipitate.  The
supernatant  was  injected  into  a  TSK  G5000PWXL  (Tosoh
Bioscience,  Montgomeryville,  PA)  size  exclusion  column
fitted to an HPLC system with an ultraviolet (UV) detector
and  equilibrated  with  PBS.  The  peak  containing  the  αB-
crystallin-peptide  complex  was  pooled  (free  of  unbound
Figure  1.  Aggregation-enhancing  and
anti-chaperone  property  of  βA3/
A1102-117 peptide. A: The effect of the
βA3/A1102–117  peptide
(SDAYHIERLMSFRPIC)  and  the
substituted  peptide
(SDADHGERLMSFRPIC) on thermal
aggregation of βL-crystallin shown. βL-
crystallin (100 μg) was incubated at 55
°C with 60 μg of the peptides for 60 min.
βA3/A1102-117  peptide  enhanced  the
light  scattering  by  denaturing  βL-
crystallin  whereas  the  substituted
peptide did not. A, βL-crystallin; B, βL-
crystallin  +  βA3/A1102–117  peptide;  C,
βL-crystallin + substituted peptide; D,
βA3/A1102–117  or  substituted  peptide
alone. B: The effect of βA3/A1102–117
peptide (SDAYHIERLMSFRPIC) and
the  substituted  peptide
(SDADHGERLMSFRPIC)  on  the
chaperone-like activity of αB-crystallin
against  denaturing  βL-crystallin  is
illustrated.  βL-crystallin  (100  μg)  was
incubated at 55 °C in the presence of 5
μg of αB-crystallin with or without 60
μg of the peptides for 60 min. In the
presence of βA3/A1102-117 peptide, the
chaperone-like activity of αB-crystallin
against  denaturing  βL-crystallin  was
lost. The substituted peptide however,
did  not  decrease  the  chaperone-like
activity  of  αB-crystallin.  A,  βL-
crystallin;  B,  βL-crystallin  +  αB-
crystallin;  C,  βL-crystallin  +  αB-
crystallin + βA3/A1102–117 peptide; D,
βL-crystallin  +  αB-crystallin  +
substituted peptide; E, αB-crystallin +
βA3/A1102–117 or substituted peptide.
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668peptide) and used in the chaperone assay as described in the
previous section.
Identification of βA3/A1102–117 peptide binding sites in αB-
crystallin: To identify the βA3/A1102–117 peptide binding sites
in αB-crystallin, the purified peptide was derivatized with
sulfo-SBED, a biotin-containing and photoactivable as well
as heterotrifunctional and amine-group specific reagent [37].
The procedure described by the supplier (Pierce) was used. In
brief, 1.78 mg of βA3/A1 peptide was dissolved in 10 μl
DMSO and the volume was made up to 50 μl with PBS. Then,
2.5 mg of sulfo-SBED dissolved in 10 μl DMSO and made up
to 50 μl with PBS was added to the peptide, and the final
volume of the reaction mixture was made up to 0.3 ml with
phosphate buffer. This achieved a threefold molar excess of
the sulfo-SBED over the peptide. The mixture was incubated
in the dark at room temperature for 45 min. The unreacted
sulfo-SBED was removed by dialyzing extensively against
PBS  using  a  1000  Da  cut-off  membrane.  Similarly,  the
substituted  peptide,  SDADHGERLMSFRPIC,  was
derivatized with sulfo-SBED for use in the interaction studies.
To  study  the  interaction  between  the  sulfo-SBED-
derivatized βA3/A1102–117 peptide (or the substituted peptide)
and αB-crystallin, 0.25 mg of the derivatized peptide was
incubated with 0.25 mg of human recombinant αB-crystallin
at 37 °C for 2 h. Subsequently, the mixture was filtered in a
10,000  Da  cut-off  centrifugal  filter  to  remove  unbound
peptide (all steps were performed in the dark). Following this,
the sample was photolyzed on an ice bath for 15 min using a
UV lamp (365 nm) held at a distance of 2 cm from the sample.
Transfer of the biotin label from the sulfo-SBED-derivatized
peptide  to  αB-crystallin  was  confirmed  by  SDS–PAGE
followed by western blot. The intensities of labeled bands in
blots  were  quantified  using  Kodak  1D  image  analysis
software (Eastman Kodak Company, Rochester, NY). The
labeled αB-crystallin was then reduced by DTT and alkylated
with iodoacetamide. Following this, the sample was dialyzed
extensively for 24 h against 50 mM Tris (pH 7.6) containing
1 mM CaCl2 using a 15,000 Da cut-off membrane and digested
by mass spectrometry grade trypsin (1:25 w/w) at 37 °C for
12 h. Trypsin digestion was terminated by the addition of the
trypsin  inhibitor,  TLCK  (1  mM);  the  sample  was  filtered
through a microcon 10 kDa filter (Millipore, Bedford, MA),
and the filtrate was collected. Trypsin-digested αB-crystallin
peptides having the biotin group derived from the sulfo-SBED
cross-linker were isolated by Pierce immobilized monomeric
avidin affinity gel chromatography [37]. The biotin-labeled
peptides were concentrated by Speed Vac, desalted by C-18
spin columns, and analyzed in an Applied Biosystems 4700
MALDI TOF/TOF mass spectrometer. The sequences of the
labeled peptides were determined by nanospray quadrupole
time-of-flight mass spectrometry (QqTOF MS/MS).
RESULTS
Effect of βA3/A1102–117 peptide on the thermal aggregation of
bovine  βL-crystallin  and  the  chaperone-like  action  of  αB-
Figure 2. Chaperone-like activity of αB-
crystallin-βA3/A1102–117  peptide
complex  against  denaturing  βL-
crystallin.  βL-crystallin  (100  μg)  was
incubated at 55 °C in presence of 5 μg
and  10  μg  of  αB-crystallin  or  αB-
crystallin-βA3/A1102–117  peptide
complex  for  60  min  and  the  light
scattering  was  measured  as  described
under  methods.  The  results  show
that  prior  interaction  of  αB-crystallin
with βA3/A1102-117 peptide diminished
its  chaperone-like  activity  against
denaturing  βL-crystallin.  A,  βL-
crystallin; B, βL-crystallin + 5 μg αB-
crystallin; C, βL-crystallin + 10 μg αB-
crystallin; D, βL-crystallin + 5 μg αB-
crystallin-βA3/A1102–117  peptide
complex; E, βL-crystallin + 10 μg αB-
crystallin-βA3/A1102–117  peptide
complex;  F,  αB-crystallin  or  αB-
crystallin-βA3/A1102–117  peptide
complex  alone.  Insert:  Relative  light
scattering by βL-crystallin in presence of
αB-crystallin  or  αB-crystallin-βA3/
A1102–117  peptide  complex.  Scattering
by  βL-crystallin  alone  at  60  min  is
considered to be 100%.
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669crystallin: The βA3/A1102–117 peptide found in aged lenses is
present in both deamidated (at Asn103) and non-deamidated
forms in vivo. Both the native peptide and the deamidated
form of the same peptide displayed similar anti-chaperone
activity (data not shown here). In this study, we used the
deamidated form of the peptide. Thermal denaturation of βL-
crystallin at 55 °C resulted in aggregation and light scattering.
The addition of the βA3/A1102–117 peptide to the incubation
mixture resulted in increased light scattering by βL-crystallin
by 58% whereas the substituted peptide increased the light
scattering only by 4% at 60 min. The βA3/A1102–117 peptide by
itself did not scatter light (Figure 1A). When the βL-crystallin
was heat-denatured in the presence of αB-crystallin, the light
scattering  was  decreased  by  41%  at  60  min  due  to  the
chaperone-like action of αB-crystallin. However, when βL-
crystallin was denatured in the presence of αB-crystallin and
βA3/A1102–117 peptide, the light scattering increased by 20%
showing the decreased chaperone action of αB-crystallin. The
substituted  peptide,  on  the  other  hand,  caused  a  slight
improvement in the chaperone action of αB-crystallin. The
light scattering by denatured βL-crystallin was decreased by
53% in the presence of αB-crystallin and substituted peptide
(Figure 1B). The αB-crystallin-βA3/A1102–117 peptide complex
showed a lowered ability to prevent thermal aggregation of
βL-crystallin.  This  complex  (5  μg)  decreased  the  light
scattering by heat-denatured βL-crystallin at 60 min by only
3% (Figure 2, curve D) as opposed to a 51% decrease caused
by an equivalent amount of the control, αB-crystallin (Figure
2, curve B). When a higher concentration of αB-crystallin-
βA3/A1102–117 peptide complex (10 μg) was used in the assay,
it caused only a 24% decrease in light scattering (Figure 2,
curve  E)  compared  to  the  81%  decrease  caused  by  an
equivalent amount of the control, αB-crystallin (Figure 2,
curve C).
Identification  of  βA3/A1102–117  peptide  binding  sites  in
recombinant αB-crystallin: Photoinsertion of the biotin label
from the derivatized βA3/A1102–117 peptide to αB-crystallin
was  confirmed  by  SDS–PAGE  and  western  blot  analysis
(Figure  3,  lane  1).  The  derivatized  substituted  peptide
incorporated  the  biotin  label  into  αB-crystallin  to  a
significantly lesser extent than the native peptide (about 1.2%
of the band intensity in western blot as compared to βA3/
A1102–117 peptide) as seen in Figure 3, lane 2.
To identify the βA3/A1102–117 peptide interacting sites in
αB-crystallin, the tryptic digest of αB-crystallin containing the
biotin-labeled  peptides  was  enriched  by  immobilized
monomeric avidin affinity gel chromatography. The masses
of the labeled peptides were determined by MALDI TOF/TOF
MS. Since sulfo-SBED contains a cleavable disulfide bond,
reduction and alkylation of the labeled αB-crystallin with
Figure 3. Western blot and SDS–PAGE
of  αB-crystallin  treated  with  sulfo-
SBED-derivatized  βA3/A1102–117
peptide  and  substituted  peptide.  The
blots  were  probed  with  avidin-
horseradish peroxidase conjugate, and
detection was done using a mixture of 4-
chloronaphthol and hydrogen peroxide.
Western blot lanes 1 and 2 correspond
to SDS–PAGE of lanes 4 and 5 stained
with Coomassie Blue.  Lane  1-  αB-
crystallin interacted with sulfo-SBED-
derivatized βA3/A1102–117 peptide; Lane
2- αB-crystallin interacted with sulfo-
SBED-derivatized  substituted  peptide;
Lane  3-  Molecular  weight  markers;
Lane  4-  αB-crystallin  interacted  with
sulfo-SBED-derivatized  βA3/A1102–117
peptide;  Lane  5-  αB-crystallin
interacted with sulfo-SBED-derivatized
substituted peptide. The arrow indicates
the position of αB-crystallin.
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670iodoacetamide will add a net mass of 603.22 Da to the mass
of  the  αB-crystallin-derived  peptide  containing  the  biotin
label. Before assigning the amino acid sequence for each
biotin-labeled αB-crystallin peptide, the presence of biotin
label in those peptides was confirmed by detection of the
fragment  ions  generating  specifically  from  sulfo-SBED
during MS/MS analysis [34]. MALDI-TOF MS spectra of
biotin-labeled  αB-crystallin  peptides  obtained  from
monomeric avidin affinity column is shown in Figure 4. The
peptide peaks labeled in Figure 4 were analyzed further by
nanospray QqTOF MS/MS. The amino acid sequence of those
peptides is indicated in the αB-crystallin sequence in Figure
5. The amino acid sequences of tryptic digest peptides of αB-
crystallin  carrying  the  biotin  label  and  their  masses  (in
parentheses)  were  70LEKDR74  (1263.64  Da),
83HFSPEELKVK92 (1816.93 Da), 91VKVLGDVIEVHGK103
(1996.06  Da),  93VLGDVIEVHGKHEER107  (2320.26  Da),
121KYR123  (1069.51  Da),  150KQVSGPER157  (1503.75  Da),
164EEKPAVTAAPK174  (1743.86  Da),  and
164EEKPAVTAAPKK175 (1871.99 Da). A peptide with a mass
of 1388.77 Da without any modifications, corresponding to
residues 1–11 in αB-crystallin, was also found among the
purified peptides.
Figure 4. MALDI-TOF MS spectrum of
biotin-labeled  αB-crystallin  tryptic
peptides  purified  by  avidin  affinity
chromatography.  Sulfo-SBED-
derivatized βA3/A1102–117 peptide was
allowed  to  interact  with  αB-crystallin
then was photolyzed and digested with
trypsin  as  described  under  Methods
before chromatography. Masses of the
αB-crystallin tryptic peptides carrying
the  biotin  label  are  indicated  in  the
figure.  The  sequences  of  these
peptides are shown in Figure 5.
Figure 5. Amino acid sequence of αB-
crystallin  showing  the  βA3/A1102–117
peptide  interacting  sites  (underlined).
The  chaperone  region  previously
identified  by  us  is  shaded  in  gray.
Biotin-labeled  αB-crystallin  peptides
were  analyzed  by  MALDI-TOF  MS,
and their sequences were assigned by
nanospray QqTOF MS/MS. The masses
of  the  biotin-labeled  αB-crystallin
peptides  are  shown  adjacent  to  their
sequences. *NH2-terminal peptide was
consistently observed in the MALDI-
TOF MS without a sulfo-SBED label.
This  peptide  may  be  interacting  with
other  labeled  peptides  and  co-eluting
during  the  monomeric  avidin
purification step.
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The presence of crystallin fragments in water-soluble and
water-insoluble fractions of lens proteins has been known for
some years [11,40]. We first suggested that anti-chaperone
peptides accumulating in vivo may be contributing to lens
opacification  during  aging  [33].  Recent  studies  in  our
laboratory have revealed the presence of 23 low molecular
weight (<3.5 kDa) peptides in the urea-soluble fractions of
normal young, normal aged, and aged cataract human lenses,
and the amount of crystallin fragments was found to increase
with  age  [36].  Our  study  also  showed  that  βA3/A1102–117
peptide,  found  in  aged  and  cataract  lens,  increased  the
scattering  of  light  by  β-  and  γ-crystallins  and  alcohol
dehydrogenase (ADH). βA3/A1102–117 peptide also exhibited
an anti-chaperone property by decreasing the ability of α-
crystallin to prevent aggregation of β- and γ-crystallins and
non-crystallin  protein  substrates,  a  process  believed  to  be
essential for maintenance of lens transparency [36].
The  present  study  has  confirmed  the  aggregation-
enhancing property of the βA3/A1-crystallin-derived peptide,
102SDAYHIERLMSFRPIC117,  since  it  promoted  the
aggregation  of  βL-crystallin  during  thermal  denaturation
(Figure 1A). The presence of this peptide in the assay mixture
reduced the ability of αB-crystallin to protect βL-crystallin
against  thermal  aggregation  (Figure  1B).  Since  the  βA3/
A1102–117  peptide  interacts  with  both  βL-crystallin  and  αB-
crystallin,  the  enhanced  light  scattering  observed  in  its
presence may be due to a combination of its interaction with
the substrate as well as the chaperone protein. To confirm the
anti-chaperone  nature  of  the  peptide,  we  pretreated  αB-
crystallin  with  βA3/A1102–117  peptide  and  separated  the
complex from the free peptide. The αB-crystallin-βA3/A1102–
117 peptide complex showed a considerable loss of chaperone-
like activity against heat-denatured βL-crystallin (Figure 2).
Since free peptide was removed before the assay, we believe
that the decreased chaperoning ability of αB-crystallin was
specifically due to the binding of the peptide to αB-crystallin.
When the βA3/A1102–117 peptide was derivatized with sulfo-
SBED,  incubated  with  αB-crystallin,  and  photolyzed,  the
biotin label transferred to αB-crystallin (Figure 3, lane 1). The
MALDI-TOF  MS  of  the  peptides  derived  from  the  αB-
crystallin by trypsin digestion showed the presence of biotin
from sulfo-SBED in several peptides (Figure 4). The identity
of those peptides was obtained by sequencing in a nanospray
QqTOF mass spectrometer. The sites on αB-crystallin where
the label was observed (Figure 5) included the sequences,
70LEKDR74 and 83HFSPEELKVK92. Earlier, we showed that
73DRFSVNLDVKHFSPEELKVK92  is  one  of  the  well
characterized  functional  chaperone  sites  in  αB-crystallin
[41].  Therefore,  we  can  conclude  that  the  anti-chaperone
peptide βA3/A1102–117 binds to αB-crystallin at the chaperone
site. The binding of the βA3/A1102–117 peptide to this substrate-
binding site in αB-crystallin may have diminished the ability
of the protein to effectively chaperone the denaturing βL-
crystallin.
Other  sites  of  interaction  between  the  βA3/A1102–117
peptide  and  αB-crystallin  included  the  sequences,
91VKVLGDVIEVHGKHEER107  and  121KYR123.  These
sequences are part of the α-crystallin domain. Earlier, Arg120
was shown to be important for the chaperone-like activity of
αB-crystallin  [42].  A  recent  study  demonstrated  that
73DRFSVNLDVKHFS85  and  101HGKHEERQDE110
sequences in αB-crystallin inhibited the fibrillation of disease-
related  amyloidogenic  proteins  including  α-synuclein  and
amyloid-β [43]. Other binding sites of the βA3/A1 peptide to
αB-crystallin  included  the  COOH-terminal  region  of
150KQVSGPER157  and  164EEKPAVTAAPKK175.  An  earlier
study has shown that mutations of the two terminal lysines
(174 and 175) of αB-crystallin to leucine or glycine greatly
reduced  its  chaperone-like  activity.  It  was  postulated  that
mutations in these two amino acids may have resulted in the
COOH-terminus folding back on itself, losing its flexibility,
and sterically hindering protein binding [44]. The COOH-
terminal  extensions  of  α-crystallins  are  considered  polar,
highly flexible, and solvent-exposed. These extensions also
act as solubilizing agents for the relatively hydrophobic α-
crystallin molecule and the high molecular weight complex
that forms during the chaperone action [45].
αB-Crystallin  with  five  amino  acids  deleted  from  its
COOH-terminus was found in lenses of hereditary cataractous
iCR/f  rat,  and  this  truncated  crystallin  showed  decreased
chaperone  activity  [46].  Protein  pin  array  studies  have
identified 157RTIPITRE164 as one of the interactive sequences
for chaperone activity in human αB-crystallin [47]. Deletion
of the polar COOH-terminal sequence, 155PERTIPITREE165,
from  human  αB-crystallin  resulted  in  poor  solubility  and
limited  or  no  chaperone  activity  against  unfolding  βL-
crystallin, alcohol dehydrogenase, and citrate synthase. These
results demonstrated the importance of the COOH-terminal
residues in the recognition, selection, and maintenance of
solubility of unfolding substrate proteins [48]. As identified
by  protein  pin-array  studies,  the  150KQVSGPER157,
164EEKPAVTAAPK174,  and  164EEKPAVTAAPKK175
sequences, which are identified as peptide interacting sites in
αB-crystallin in the present study, overlap with sequences
involved  in  dimerization  and  assembly  of  human  αB-
crystallin [49]. The binding of the βA3/A1102–117 peptide to the
COOH-terminal  extension  of  αB-crystallin  in  the  present
study  may  have  interfered  with  substrate  binding  and
decreased the chaperoning ability of the protein. Our recent
studies showed that the βA3/A1102–117 peptide caused partial
precipitation of αB-crystallin [36]. We believe that the peptide
interaction at the COOH-terminal extension of αB-crystallin
may  have  led  to  decreased  flexibility  and  decreased
solubilization  potential  of  αB-crystallin.  Additionally,  the
interactions between crystallins and low molecular weight
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672peptides may limit the access of these peptides to peptidases,
resulting in the accumulation of peptides with aging.
The  substituted  peptide  we  used  in  this  study,
SDADHGERLMSFRPIC,  had  two  hydrophobic  residues
(tyrosine and isoleucine) replaced by hydrophilic (aspartate
and glycine) residues. The substitution abolished the ability
of the peptide to induce βL-crystallin aggregation (Figure 1A)
and to act as anti-chaperone (Figure 1B). This suggests that
the  hydrophobic  amino  acids  play  a  critical  role  in  the
interaction of the anti-chaperone peptide with αB-crystallin.
The  substituted  peptide  can  also  be  considered  a  control
peptide for the label transfer study. If there were any non-
specific  interactions  between  the  derivatized  substituted
peptide and αB-crystallin, we would have seen a transfer of
biotin to αB-crystallin following photolysis. The fact that the
αB-crystallin incubated with derivatized substituted peptide
showed only about 1.2% of the label transfer when compared
to the derivatized βA3/A1102–117 peptide during the blotting
experiments (Figure 3 lane 2) suggests that the non-specific
interaction and label transfer was insignificant in this study.
In  summary,  this  study  confirmed  the  interactions
between βA3/A1102–117 peptide and αB-crystallin. The binding
of this peptide to regions critical for chaperone action of αB-
crystallin  may  explain  its  anti-chaperone  property.  The
modulation  of  structural  and  functional  properties  of
crystallins by low molecular weight peptides may play an
important role in protein aggregation and cataract formation.
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